KBI Biopharma SA: KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in Geneva, Switzerland

The KBI and Selexis co-location will expand biopharmaceutical development and manufacturing capabilities to serve the global demand for novel therapies. KBI Biopharma SA (KBI) and Selexis SA, both

Related Keywords

Geneva ,Genè ,Switzerland ,United States ,Plan Les Ouates ,Swiss ,Luca Bolliger ,Mark Lutgen ,Blair Ciecko ,Kostenloser Wertpapierhandel ,Tim Lowery ,Markw Womack ,Aruna Mor ,Mike Beyer ,Fabienne Fischer ,Mario Rodriguez ,Maria Pilar Gimenez ,Selexis Sa Company Inquiries ,Biopharma Company Inquiries ,Sam Brown Inc ,Biopharma Inc ,Swiss Biotech Association ,Life Sciences Photo ,Head Of The Department ,Life Sciences ,Global Engineering ,State Councilor ,Chief Executive Officer ,Business Wire ,Swiss Biotech Success Stories Jury ,State Councilor Member ,Company Inquiries ,Pilar Gimenez ,Media Inquiries ,Biopharma ,Selexis ,Gold ,Joint ,Gibbon ,Cutting ,Xpanded ,Estate ,Facility ,